The purpose of this protocol is to examine if the new polysaccharide- protein-linked (Ps-conjugate) vaccines can induce early and protective antibody responses in bone marrow transplant patients. The value of donor immunization will be documented and an optimal immunization schedule will be determined.
Showing the most recent 10 out of 721 publications